Cargando…

First-Trimester Screening for HELLP Syndrome—Prediction Model Based on MicroRNA Biomarkers and Maternal Clinical Characteristics

We evaluated the potential of cardiovascular-disease-associated microRNAs for early prediction of HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Gene expression profiling of 29 microRNAs was performed on whole peripheral venous blood samples collected between 10 and 13 weeks...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hromadnikova, Ilona, Kotlabova, Katerina, Krofta, Ladislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049724/ https://www.ncbi.nlm.nih.gov/pubmed/36982251 http://dx.doi.org/10.3390/ijms24065177

Ejemplares similares

First-Trimester Screening for Miscarriage or Stillbirth—Prediction Model Based on MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2023)

First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

Cardiovascular Disease-Associated MicroRNAs as Novel Biomarkers of First-Trimester Screening for Gestational Diabetes Mellitus in the Absence of Other Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

First Trimester Prediction of Preterm Delivery in the Absence of Other Pregnancy-Related Complications Using Cardiovascular-Disease Associated MicroRNA Biomarkers
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

First trimester screening of circulating C19MC microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR
por: Hromadnikova, Ilona, et al.
Publicado: (2017)

Novel First-Trimester Prediction Model for Any Type of Preterm Birth Occurring before 37 Gestational Weeks in the Absence of Other Pregnancy-Related Complications Based on Cardiovascular Disease-Associated MicroRNAs and Basic Maternal Clinical Characteristics
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

The Prediction of Gestational Hypertension, Preeclampsia and Fetal Growth Restriction via the First Trimester Screening of Plasma Exosomal C19MC microRNAs
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

First Trimester Screening of Circulating C19MC microRNAs Can Predict Subsequent Onset of Gestational Hypertension
por: Hromadnikova, Ilona, et al.
Publicado: (2014)

Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2022)

A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Association Analysis in Young and Middle-Aged Mothers—Relation between Expression of Cardiovascular Disease Associated MicroRNAs and Abnormal Clinical Findings
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Postnatal Expression Profile of MicroRNAs Associated with Cardiovascular Diseases in 3- to 11-Year-Old Preterm-Born Children
por: Hromadnikova, Ilona, et al.
Publicado: (2021)

Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2015)

Expression profile of C19MC microRNAs in placental tissue of patients with preterm prelabor rupture of membranes and spontaneous preterm birth
por: Hromadnikova, Ilona, et al.
Publicado: (2017)

Association Analysis in Children Born from Normal and Complicated Pregnancies—Cardiovascular Disease Associated microRNAs and the Incidence of Prehypertension/Hypertension, Overweight/Obesity, Valve Problems and Heart Defects
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Maternal Cardiovascular Risk Assessment 3-to-11 Years Postpartum in Relation to Previous Occurrence of Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

Postnatal Expression Profile of microRNAs Associated with Cardiovascular and Cerebrovascular Diseases in Children at the Age of 3 to 11 Years in Relation to Previous Occurrence of Pregnancy-Related Complications
por: Hromadnikova, Ilona, et al.
Publicado: (2019)

Substantially Altered Expression Profile of Diabetes/Cardiovascular/Cerebrovascular Disease Associated microRNAs in Children Descending from Pregnancy Complicated by Gestational Diabetes Mellitus—One of Several Possible Reasons for an Increased Cardiovascular Risk
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics
por: Hromadnikova, Ilona, et al.
Publicado: (2020)

Circulating C19MC MicroRNAs in Preeclampsia, Gestational Hypertension, and Fetal Growth Restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2013)

Circulating heat shock protein mRNA profile in gestational hypertension, pre-eclampsia & foetal growth restriction
por: Hromadnikova, Ilona, et al.
Publicado: (2016)

Extracellular chromosome 21-derived microRNAs in euploid & aneuploid pregnancies
por: Kotlabova, Katerina, et al.
Publicado: (2013)

The screening of diagnostic biomarker microRNA in first-trimester maternal plasma for Down syndrome: A study protocol
por: He, Fengping, et al.
Publicado: (2022)

Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp 70 Derived 14-Mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors on Peripheral Blood T Cells, B Cells and NKT Cells
por: Hromadnikova, Ilona, et al.
Publicado: (2016)

Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia
por: Torres-Torres, Johnatan, et al.
Publicado: (2023)

First Trimester Circulating MicroRNA Biomarkers Predictive of Subsequent Preterm Delivery and Cervical Shortening
por: Cook, Joanna, et al.
Publicado: (2019)

Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and Biomarkers
por: Malone, Sarah L, et al.
Publicado: (2022)

Human Placenta MicroRNA Differences Between First and Third Trimester
por: Gonzalez, Tania L, et al.
Publicado: (2021)

Maternal Body Mass Index Is Associated with Profile Variation in Circulating MicroRNAs at First Trimester of Pregnancy
por: Thibeault, Kathrine, et al.
Publicado: (2022)

Combinatorial Analysis of Circulating Biomarkers and Maternal Characteristics for Preeclampsia Prediction in the First and Third Trimesters in Asia
por: Lin, Willie, et al.
Publicado: (2022)

Maternal, prenatal and perinatal characteristics and first trimester maternal serum hormone concentrations
por: Troisi, R, et al.
Publicado: (2008)

A Bioplex Analysis of Cytokines and Chemokines in First Trimester Maternal Plasma to Screen for Predictors of Miscarriage
por: Hannan, Natalie J., et al.
Publicado: (2014)

Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Complete Blood Count Components in the First Trimester Do Not Predict HELLP Syndrome
por: Sisti, Giovanni, et al.
Publicado: (2019)

Maternal cardiovascular and endothelial function from first trimester to postpartum
por: Kolovetsiou-Kreiner, Vassiliki, et al.
Publicado: (2018)

Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening
por: Moungmaithong, Sakita, et al.
Publicado: (2023)

Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome
por: Kongwattanakul, Kiattisak, et al.
Publicado: (2018)

Early Second-Trimester Serum MicroRNAs as Potential Biomarker for Nondiabetic Macrosomia
por: Hu, Lingmin, et al.
Publicado: (2014)

Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy
por: Luque, Ana, et al.
Publicado: (2014)

First Trimester Plasma MicroRNA Levels Predict Risk of Developing Gestational Diabetes Mellitus
por: Légaré, Cécilia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9fgfs1rf42knmee91pqel7amp7